SELLAS Life Sciences Group, Inc. Earnings Per Share (Diluted)
SELLAS Life Sciences Group, Inc. (SLS) reported Earnings Per Share (Diluted) of -$0.05 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-11
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.05.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.05.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.06.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for the quarter ending 2025-06-30 was -$0.07.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for fiscal 2025 was -$0.25.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for fiscal 2024 was -$0.50.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for fiscal 2023 was -$1.34.
- SELLAS Life Sciences Group, Inc. earnings per share, diluted for fiscal 2022 was -$2.13.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.05 10-Q · filed 2026-08-11 | -$0.10 10-Q · filed 2026-08-11 | ||||
| 2026-03-31 | -$0.05 10-Q · filed 2026-05-12 | |||||
| 2025-12-31 | -$0.25 10-K · filed 2026-03-19 | |||||
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-12 | -$0.20 10-Q · filed 2025-11-12 | ||||
| 2025-06-30 | -$0.07 10-Q · filed 2026-08-11 | -$0.13 10-Q · filed 2026-08-11 | ||||
| 2025-03-31 | -$0.07 10-Q · filed 2026-05-12 | |||||
| 2024-12-31 | -$0.50 10-K · filed 2026-03-19 | |||||
| 2024-09-30 | -$0.10 10-Q · filed 2025-11-12 | -$0.42 10-Q · filed 2025-11-12 | ||||
| 2024-06-30 | -$0.13 10-Q · filed 2025-08-12 | -$0.33 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | -$0.21 10-Q · filed 2025-05-13 | |||||
| 2023-12-31 | -$1.34 10-K · filed 2025-03-20 | |||||
| 2023-09-30 | -$0.33 10-Q · filed 2024-11-13 | -$1.09 10-Q · filed 2024-11-13 | ||||
| 2023-06-30 | -$0.31 10-Q · filed 2024-08-13 | -$0.77 10-Q · filed 2024-08-13 | ||||
| 2023-03-31 | -$0.47 10-Q · filed 2024-05-14 | |||||
| 2022-12-31 | -$2.13 10-K · filed 2024-03-28 | |||||
| 2022-09-30 | -$0.34 10-Q · filed 2023-11-09 | -$1.70 10-Q · filed 2023-11-09 | ||||
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-10 | -$1.39 10-Q · filed 2023-08-10 | ||||
| 2022-03-31 | -$1.05 10-Q · filed 2023-05-11 | |||||
| 2021-12-31 | -$0.42 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.17 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.34 10-K · filed 2023-03-16 | ||
| 2021-09-30 | -$0.45 10-Q · filed 2022-11-14 | -$0.75 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.92 10-Q · filed 2022-11-14 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-11-14 | ||
| 2021-06-30 | -$0.30 10-Q · filed 2022-08-11 | -$0.47 10-Q · filed 2022-08-11 | -$0.79 derived: net income ÷ weighted average shares · filed 2022-08-11 | -$1.24 derived: net income ÷ weighted average shares · filed 2022-08-11 | ||
| 2021-03-31 | -$0.16 10-Q · filed 2022-05-12 | -$0.48 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$0.94 derived: net income ÷ weighted average shares · filed 2022-05-12 | -$1.49 derived: net income ÷ weighted average shares · filed 2022-05-12 | ||
| 2020-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$0.87 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$1.48 derived: net income ÷ weighted average shares · filed 2022-03-31 | -$2.11 10-K · filed 2022-03-31 | ||
| 2020-09-30 | -$0.53 10-Q · filed 2021-11-12 | -$1.18 derived: net income ÷ weighted average shares · filed 2021-11-12 | -$1.83 10-Q · filed 2021-11-12 | |||
| 2020-06-30 | -$0.66 10-Q · filed 2021-08-12 | -$1.32 10-Q · filed 2021-08-12 | ||||
| 2017-06-30 | -$0.22 10-Q · filed 2017-08-14 | -$0.63 10-Q · filed 2017-08-14 | ||||
| 2016-06-30 | $0.58 10-Q · filed 2017-08-14 | -$0.30 10-Q · filed 2017-08-14 | ||||
| 2013-06-30 | -$0.11 10-Q · filed 2013-08-09 | -$0.23 10-Q · filed 2013-08-09 | ||||
| 2012-06-30 | -$0.03 10-Q · filed 2013-08-09 | -$0.01 10-Q · filed 2012-08-14 | -$0.44 10-Q · filed 2013-08-09 | -$0.45 10-Q · filed 2012-08-14 | ||
| 2011-06-30 | -$0.10 10-Q · filed 2012-08-14 | -$0.26 10-Q · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Mineralys Therapeutics, Inc. (MLYS) | United States | $2.353B | -6.82 |
| Viridian Therapeutics, Inc.\DE (VRDN) | United States | $2.342B | -5.38 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Zai Lab Ltd (ZLAB) | $2.241B | -113.34 |